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Summary Cancer mortality in 40 761 employees of three UK nuclear industry facilities who had been monitored for extemal radiation
exposure was examined according to whether they had also been monitored for possible intemal exposure to tritium, plutonium or other
radionuclides (uranium, polonium, actinium or other unspecified). Death rates from cancer were compared both with national rates and with
rates in radiation workers not monitored for exposure to any radionuclides. Among workers monitored for tritium exposure, overall cancer
mortality was significantly below national rates [standardized mortality ratio (SMR) = 83, 165 deaths; 2P = 0.02] and none of the cancer-
specific death rates was significantly above either the national average or rates in non-monitored workers. Although the overall death rate
from cancer in workers monitored for plutonium exposure was also significantly low relative to national rates (SMR = 89, 581 deaths; 2P =
0.005), mortality from pleural cancer was signfficantly raised (SMR = 357, nine deaths; 2P = 0.002); none of the rates differed significantly
from those of non-monitored workers. Workers monitored for radionuclides other than tritium or plutonium also had a death rate from all
cancers combined that was below the national average (SMR = 86, 418 deaths; 2P= 0.002) but prostatic cancer mortality was raised both in
relation to death rates in the general population (SMR = 153, 37 deaths; 2P = 0.02) and to death rates in radiation workers who had not been
monitored for exposure to any radionuclide [rate ratio (RR) = 1.65; 2P = 0.03]. Mortality from cancer of the lung was also significantly
increased in workers monitored for other radionuclides compared with those of radiation workers not monitored for exposure to radionuclides
(RR = 1.31. 164 deaths; 2P = 0.01). For cancers of the lung, prostate and all cancers combined, death rates in monitored workers were
examined according to the timing and duration of monitoring for radionuclide exposure, with rates of radiation workers not monitored for any
radionuclide forming the comparison group. In tritium-monitored workers, RRs for prostatic cancer varied significantly according to the
number of years in which they were monitored (2P = 0.03). In workers monitored for plutonium exposure, RRs for all cancers combined
increased with the number of years in which they were monitored (2P = 0.04) and with the number of years since first monitoring
(2P = 0.0003). There was little suggestion of systematic variation in RRs for workers monitored for other radionuclides in relation to the timing
or duration of monitoring. nor did it appear that their raised rates of cancer of the lung and prostate were explained by extemal radiation dose.
These analyses of cancer mortality in relation to monitoring for radionuclide exposure reported in a large cohort of nuclear industry workers
suggest that certain pattems of monitoring for some radionuclides may be associated with higherdeath rates from cancers of the lung, pleura.
prostate and all cancers combined. Some of these findings may be due to chance. Moreover, because of the paucity of related data and lack
of information about other possible exposures, such as whether plutonium workers are more likely to be exposed to asbestos, firm
conclusions cannot be drawn at this stage. Further investigations of the relationship between radionuclide exposure and cancer in nuclear
industry workers are needed.
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Several large epidemiological studies have examined cancer
mortalitv in nuclear industr-,-workers in relation to occupational
exposure to external ionizinc radiation. and combined analvses of
mortalitx have been published recently for the UK (Kendall et al,
1992: Carpenter et al. 1994) and for the US and Canada (Gilbert et
al. 1993: Cardis et al. 1995). These studies have provided detailed
information about the relationship bet-ween cancer risk in popula-
tions occupationally exposed to low-lesel ionizinc radiation from
external sources. The effects of occupational exposure to internal
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sources of radiation from radionuclides (such as tritium or pluto-
mum) hase. ho%vesver. been little studied. These exposures occur in
work environments where there are unsealed sources of radioac-
tive material. when particles may enter the body bx inhalation.
ingestion or accidentally throuch a wound.
Excess risks of lunr cancer hase been documented in miners
exposed to a-particle-emitting radon progeny (Lubin et al. 1995).
but the effects of internal exposures typically found in the nuclear
industrv are less certain. Increased risks ofbone and head and neck
cancers has e been associated w-ith occupational exposure to
radium and of lung cancer associated with occupational exposure
to plutonium (Wilkinson et al. 1987: Checkowasv et al. 1988:
National Research Council. 1988: UNSCEAR. 1994:
Koshurnikosa et al. 1997). Our presious analx-ses of mortalitv in
employees of the UK Atomic Energry Authoritx (AEA) and the
1224Cancermortalityandmonitonng forradionuclide exposure 1225
Table 1 Numbers (per cent) of radiatn workers in three UK workkorces (AEA, AWE, Sellafel according to their radionucide monitonng status and sex
Totd nunber of Not monitored for Ever monitored for
mdation worarny aclonucide
Trium Plutonium Other radionucides
Male 37395 (100%) 20521 (54.9%) 3 986 (10.7%) 11 942 (31.9%) 9 772 (26.1%)
Female 3 366 (100%) 2 635 (78.3%) 125 (3.7%) 556 (16.5%) 413 (12.3%)
Total 40761 (100%) 23156(56.8%) 4111 (10.1%) 12498(30.7%) 10185(25.0%)
aGroups notmubuallyexdcusie: of 17 605 workers monitored for any radionuclide, 9949 were montored fortritium alone, plutonium alone oroher radionucides
alone.
Atomic Weapons Establishment (AWE) suggested that workers
who had been monitored for radionuclides were at increased risk
ofcancer ofthe prostate and possibly also oflung cancer (Beral et
al, 1988; Fraser et al, 1993). The association with prostatic cancer
was investigated in detail in a nested case-control study of
employees of the AEA (Rooney et al, 1993). This revealed
increased risks among workers occupationally exposed to tritium,
5"Cr, 59Fe, 6OCo or 65Zn, but the effects of these individual radio-
nuclides could not be disentangled.
We have previously reported combined analyses of cancer
mortality in relation to exposure to external radiation for three UK
cohorts comprising employees of the AEA, the AWE and the
Sellafield plant of British Nuclear Fuels Limited (BNFL)
(Carpenter et al, 1994). In the present report we examine cancer
mortality of workers in these three cohorts who had been moni-
tored for exposure to external radiation according to whether or
not they were also monitored for internal exposure to tritium or
plutonium and (for AEA and AWE employees only) to other
radionuclides (uranium, polonium, actinium or other unspecified).
Particular attention is given in the analyses to mortality from
cancers of the lung and prostate because these cancers have been
associated with the specific type ofradionucides to which nuclear
industry workers are exposed.
MATERIALS AND METHODS
Study popu bo and personn dat
The study population derives from the combined cohort of 75 006
employees that formed the basis ofour previous report (Carpenter
et al, 1994). This comprised all individuals who had worked at the
AEA establishments at Harwell (with Culham and London),
Dounreay or Winfrith before 1980, at the AWE before 1983 or at
Sellafield before 1976. The present analyses relate to the subset of
40 761 monitored workers for whom personal dose records had
been maintained by one or more of the contributing establish-
ments. Details are provided elsewhere ofthemethods used fordata
collection and validation separately for each contributing cohort
(Beral et al, 1985, 1988; Fraser et al, 1985, 1993; Smith and
Douglas, 1986; Douglas et al, 1994; Inskip et al, 1987) and forthe
assembly ofdata for the combined study (Carpenter et al, 1994).
Moality dat
Deaths and emigrations reported in cohort members by the
National Health Service Central Registers (NHSCRs) up to the end
of 1988 were included, as in our previous analyses (Carpenteret al,
1994). All analyses were based on the underlying causeofdeath (as
stated on the death certificate) coded according to the International
Classification of Diseases (ICD) (World Health Organization,
1967, 1977). Deaths for which an underlying cause could not be
ascertained were included in analyses of death from all causes but
not in cause-specific analyses. The present analyses are based on a
total of6944deaths in workers monitoredforradiation exposure, of
which 1895 were from cancer. This includes 11 additional cancer
deaths identified following the introuction of the new computer-
ized system at NHSCR in Southport that were not available for
inclusion in ourprevious analyses (Carpenter et al. 1994).
Radiation data
For AEA and AWE employees, information on annual monitoring
of personnel for possible intake of radionucides [tritium, pluto-
nium and other radionucides (uranium, polonium, actinium and
other unspecified)] was provided in the form of a set of annual
flags for each worker, indicating for each year whether they had
been monitored for each radionucide or group of radionuclides.
For Sellafield workers, information on radionuclide monitoring
was available for plutonium and tritium only and was limited to
the year in which the worker was first monitored foreach radionu-
clide. There was insufficient detail about radionucides other than
tritium orplutonium to warrant separate analysis. Data on external
radiation dose were obtained from records held by the three indus-
tries, and the methods used in their assembly have been described
in detail previously (Beral et al, 1985, 1988; Fraser et al, 1985,
1993; Smith and Douglas, 1986; Inskip et al, 1987; Douglas et al,
1994). For the majority of the study period, regulatory dose
records did not generally include doses to organs from the intake
ofradioactivity (internal dose) (Carpenter et al, 1994).
S_tial Imeods
Workers contributed person-years (PY) at risk from their earliest
date of first monitoring for radiation at AEA. AWE or Sellafield
through to 31 December 1988 or their date of emigration, date of
death or the date they were last traced, if any of these preceded 1
January 1989. PY at risk and deaths were stratified by sex, age in
15 groups (15-, 20-, ... 85+ years), calendar year in single years
(for comparisons with national rates) and in nine groups (1946,
1950-. 1955-, ... 1985-88, for all other analyses), last establish-
ment in five groups (Harwell with Culham and London. Dounreay.
Wmfrith, AWE, Sellafield) and social class in up to four groups
(I+H, Ill non-manual, III manual and IV+V coded according to the
British Registrar General's Classification (Office of Population
Censuses and Surveys, 1970) for AEA and AWE; non-industrial
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Table 2 Stndardized mortaity ratis (SMRs) and rate raiosb (RRs) for specfic cancers in raiaion works in three UK worforces (AEA, AWE, Selialel
accordn to their radinuclde mnioring status
NoR monired Ever monitored for
for any
adonuclide TrWkum Pluonim Other radioucides
Causeof dinth SUR SUR RR (95% CI) SWR RR(95% Cl) SMR RR(95% C)
(lCD 8th evvon code) (ob ved d (obserd (o ved
-) d-) d) d)
Al malinant neoplsm (140-209)
Buccal cavity and pharynx (140-149)
Oesophagus (150)
Stomach (151)
Sial iestin (152)
Large itesti (153)
fRctum (154)
Uver and gal bldder (155-156)
Pancreas (157)
Nasal cavites and sinuses (160)
Larynx (161)
Bronchus and lug (162)
Pleura (163)
Bone (170)
Connective tissue (171)
Melanmwa and other sin (172-173)
Breast (174-175)
Al female genital (180-184)
Uterus (180-182)
Ovary (183)
Al male genital (185-187)
Prostate (185)
Testis (186)
Bladder (188)
Kciniey (189.0)
Brain and other central nervous
systemf (191-192, 225, 238)
Thyr (193)
1l-defried and secodary (195-199)
Al lynhac and haematopoietic
(200-209)
Non-Hgdn's lyrna
(200,202)
Hodgidn's disease (201)
Mule myom (203)
Leukaeml (204-208)
Leukaemia excding CLL
Causesohe than
cancer(0-139,210-999)
Al causes (0-999)
Number of workers Monitored
80- (1097)
88 (18)
89 (37)
87 (114)
110 (3)
96 (84)
75 (46)
51P (9)
82 (47)
108 (3)
48 (6)
68- (348)
209 (9)
83 (4)
111 (5)
58 (8)
64(16)
121 (18)
144 (10)
95 (7)
89 (69)
90 (62)
111(7)
90 (44)
89 (21)
79 (36)
269- (7)
95 (60)
93 (87)
83- (165)
-(0)
88 (6)
62(11)
249 (1)
81 (10)
57 (5)
111 (3)
92 (8)
246 (1)
53(1)
73* (57)
115 (1)
181 (1)
-(0)
148 (3)
-(0)
203 (1)
442 (1)
- (0)
164 (17)
150 (14)
401 (3)
116 (8)
78 (3)
86 (6)
-(0)
100 (10)
88(12)
1.02 (0.86-1.21)
0.0 (0.0-0.90)
0.86 (0.32-1.97)
0.68 (0.34-1.23)
1.10(0.05-10.69)
0.75 (0.36-1.41)
0.74 (025-1.77)
2.32 (0.43-9.99)
1.09 (0.46-2.24)
1.33 (0.06-12.53)
2.10 (0.10-15.58)
1.18 (0.87-1.58)
0.48 (0.03-2.69)
1.31 (0.05-14.71)
0.0 (00-4.57)
1.50 (0.31-5.78)
0.0 (0.0-2.31)
1.95 (0.10-13.04)
2.99 (0.13-30.03)
0.0 (0.0-34.49)
1.61 (0.88-2.79)
1.33 (0.69-2.41)
8.37T (1.48-43.14)
1.51 (0.64-3.17)
0.65 (0.15-1.97)
1.08 (0.40-2.48)
0.0(0.0-2.50)
0.93 (0.43-1.82)
1.03 (0.52-1.87)
89- (581)
30-(3)
108 (23)
89 (54)
307 (4)
94 (38)
87 (25)
70 (6)
68 (19)
151 (2)
65 (4)
85- (217)
357- (9)
100 (2)
45(1)
46 (3)
117 (5)
189 (4)
203 (2)
186 (2)
102 (36)
101 (32)
152 (4)
65 (15)
100 (12)
76 (17)
85(1)
121 (38)
92 (41)
109 (29) 167 (7) 1.90 (0.74-4.30) 129 (17)
55(7)
53 (8)
117(43)
-d (34)
65(1)
42(1)
59 (3)
-d (3)
0.94(0.05-6.16)
0.63 (0.03-3.74)
0.55 (0.13-1.59)
0.66 (0.15-1.98)
110 (6)
79 (6)
65(11)
.d (9)
1.01 (0.90-1.13)
0.29a(0.07-0.94)
0.81 (0.46-1.39)
0.85 (0.60-1.21)
2.31 (0.46-13.45)
0.84 (0.55-1.26)
1.02 (0.59-1.75)
2.00 (0.59-6.38)
0.72 (0.40-1-27)
1.23(0.14-9.18)
2.55 (0.58-10.87)
1.18 (0.97-1.42)
1.97 (0.71-5.49)
1.01 (0.12-7.35)
0.35 (0.02-2.43)
0.50 (0.11-1.88)
2.17 (0.63-6.70)
2.14 (0.52-7.78)
1.67 (0.22-9.63)
4.88 (0.49-48.44)
0.99 (0.63-1.53)
0.90 (0.56-1.43)
2.36(0.55-8.91)
0.72 (0.37-1.34)
0.89 (0.41-1.87)
0.89 (0.46-1.66)
0.15- (0.01-0.89)
1.11 (0.71-1.72)
1.04 (0.69-1.56)
86- (418)
13(1)
56 (9)
79 (35)
207(2)
79(24)
70(15)
77(5)
48- (10)
203 (2)
44(2)
86 (164)
200 (4)
142 (2)
60(1)
102 (5)
33(1)
201 (3)
432 (3)
- (0)
142 (38)
153' (37)
53(1)
46- (8)
110 (10)
85 (14)
-(0)
137 (33)
87 (29)
1.48 (0.76-2.83) 120 (12)
1.44 (0.41-5.16)
1.05 (0.33-3.21)
0.62 (029-1.23)
0.58 (025-1.24)
79 (3)
87 (5)
72 (9)
d (7)
1.09 (0.96-1.23)
0.13a(0.01-0.69)
0.46' (020-0.97)
1.04 (0.67-1.57)
1.00 (0.13-6.47)
0.81 (0.49-1.31)
0.93 (0.48-1.73)
1.16(0.32-3.74)
0.53 (024-1.05)
225 (0.24-20.47)
0.97 (0.13-5.07)
1.31'(1.06-1.61)
1.62 (0.3-6.27)
2.07 (0.21-18.61)
1.27(0.06-12.63)
1.76(0.42-7.32)
0.54 (0.03-3.05)
2.56 (0.52-9.57)
7.28- (1.10-47.81)
0.0 (0.0-6.42)
1.56(0.99-2.47)
1.65- (1.03-2.65)
0.60(0.03-4.12)
0.56 (023-1.19)
1.53 (0.63-3.57)
1.26 (0.61-2.51)
0.0' (0.0-0.88)
1.50 (0.92-2.41)
0.85 (0.53-1.33)
0.90 (0.43-1.81)
1.02(0.19-4.73)
1.98 (0.53-7.28)
0.58 (0.25-1.22)
0.56 (0.21-1.29)
80* (3052) 72- (363) 0.88' (0.78-0.98) 88- (1508) 0.97 (0.91-1.04) 76- (967) 0.94 (0.86-1.01)
80D (4149) 75- (528) 0.92(0.83-1.01) 88* (2089) 0.98(0.93-1.04)
23 156 4111 12 498
79- (1385) 0.98 (0.91-1.05)
10 185
ausing age-, sex-, and caleniryear-specific rates in Engand andWales. bRelative to radion not moni for anyradonucle,acpusted for age,
sex, calendar period, social class and establisment cncudes benign and unsecfi neopds ofnervous systeM. dRates forEngWnd andWales not
avalable. Sifcance ofdifferece from 100 (SMR) or 1 (RR), *2P< 0.05; '2P< 0.01; '2P< 0.001.
and industrial for Sellafield). Ten employees missing vital infor-
mation (e.g. date ofbirth) were excluded from all analyses and 36
employees who could not betraced at the NHSCRs contributed PY
at risk until their date oflast employment.
Radionucide monxitoring status was trated as a time-dependent
variable in all analyses. For example, a plutonium-monitored
worker's PYatriskwere addedtothoseofworkers notmonitoredfor
anyradionuclide uptothedate inwhichthey werefirstmonitoredfor
plutonium, afterwhichtheirPYatnsk(anddeath, ifapplicable) were
added to the plutonium-monitowred goup. Similarly, for tim-depen-
dent variables such as time since first monitoring (classified in three
levels: < 10 years, 10-19 years and 20+ years) workers contributed
PY at nsk to the first category until their tenth anniversary of first
monitoring, after which they contributed to the second category and
so on.
For radionuclide-monitored workers, and those not monitored
for any radionucide, age, sex and calender year-specific death
rates were assessed relative to those for England and Wales and
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Table 3 Rate ratiosa for death from all malignant neoplasms and selected cancers in radiation workers in three UK workforces (AEA, AWE. Sellafleld)
monitored for radionudlides according to bime since first monitoring
Rate ratio (number of deaths)
Time since first mionitoring (years) Chi-square statistics for
Cause of death Radionuclide <10 years 10G-19 years 20+ years Heterogen'~eity Trend (d.f. =1)
(lCD 8th revisio code) monitored for (d.f. = 2)
All malignant Tritum 1.06 (55) 0.97 (59) 1.05 (51) 0.21 0.004
neoplasms (140-209) Plutonium 0.79- (113) 0.95 (175) 1.20- (293) 12.91 ~ 12.86"'
Other 1.00 (121) 1.09(164) 1.18 (133) 1.57 1.57
Bronchusandlung(162) Tnitium 1.18(19) 1.25(23) 1.09(15) 0.16 0.03
Plutonium 0.95 (45) 1.26 (74) 1.26 (98) 2.49 1.69
Other 1.36 (54) 1.22 (60) 1.37 (50) 0.42 0.002
Prostate (185) Tritium 1.98 (5) 1.47 (6) 0.79 (3) 1.54 1.46
Plutonium 0.96 (5) 0.83 (10) 0.94 (17) 0.11 0.01
Other 1.41 (7) 1.48(15) 2.02' (15) 0.81 0.69
aRelative to radiation workers not monitored for any radionudlide, adjusted for age, sex, calendiar period, social class and establishment.
Statistical significance, 2P< 0.05 **2P< 0.01 ...2P < 0.001.
Table 4 Rate ratioSa for death from selected cancers in AEA and AWE radiatio workers monitored for radionudlide exposure according to number of years in
which they were monitored
Rate ratio (number of deaths)
Number of years in which monitored Chi-square staftitics for
Cause of death Radionuclide 1 year only 2-4 years 5+ years Heteogeneity Trend (d.f. =1)
(lCD 8th revision code) mfonitored for (d.f. =2)
All malignant Tritium 1.01 (42) 0.97 (37) 1.08 (43) 0.21 0.08
neoplasms (140-209) Plutonium 0.85 (60) 0.92 (84) 1.15 (156) 4.65 4.38'
Other 1.13(103) 1.06(138) 1.10(177) 0.24 0.04
Bronchusandlung(162) Tritium 1.12(14) 1.09(12) 1.25(15) 0.15 0.09
Plutonium 1.09 (25) 0.99 (28) 1.45' (62) 3.16 2.05
Other 1.47' (44) 1.09 (45) 1.40' (75) 2.47 0.0001
Prostate (185) Tritium 0.31 (1) 3.19' (6) 2.26 (5) 7.16' 3.18
Plutonium 0.45 (2) 1.79 (8) 1.15 (10) 3.45 0.57
Other 1.37(7) 2.06' (14) 1.55 (16) 0.89 0.003
aRelative to radiatio workers not monitored for any radionuclide. adjusted for age, sex, calendar period, social class and establishment. Statistical significance,
*2P < 0.05.
summarized using, standardized mortalitv ratios (SMRs) using,
identical methods to those previously employed (Carpenter et al.
1994). Mortality in monitored workers was also compared A-ith
that of xAorkers not monitored for anv radionuclide. without refer-
ence to national rates. using rate ratios (RRs) estimated with
adjustment for age. sex. calendar period. estabhishment and social
class using, the likelihood-based methods, as described prev-iouslv
(Carpenteretal. 1994).
For selected cancers. death rates were examined accordingy to a
number ofcharacteristics associated with radionuclide monitoiring:
time since first monitoring. the number of years in which w-orkers
were monitored (A]EA and AWE only). age at first monitorngnc and
calendar year of first monitoring. For each of these variables, a set
of k-l RR estimates were obtained by adding, k-I term-s to a log-
linear model that included terms representing age. sex. calendar
period. establishment. social class and monitoring status. A test of
heterogreneitv in the RRs was obtained comparing the resulting,
reduction in deviance to a chi-square distribution with K-i degrees
of freedom. Approximate test statistics for trend were obtained in a
similar manner by adding to the basic model a singyle term to repre-
sent the variable on a continuous scale. All RRs wvere estimated
using the AMFIT computer program (Preston et al. 1993).
Dose-response analyses of mortalitv accordingy to cumulative
whole-body (extemnal) dose werecarried' out separatelv for workers
monitored for any radionuclide and u-orkers not monitored for any
radionuclide using, seven dose categories (<10. 10-. 20-. 50-.
100--. 200-. 400+ mSv%). Summarv z statistics and one-sided P-
values (lP) for trend in whole-bodv dose were calculated from
analyses stratified according, to age. sex. calendar period, estabhish-
ment and social class, as before (Carpenter et al. 1994). All other
tests of statistical significance were assessed using two-sided P-
v-alues (2P). Attention is drawn to results signi'ficant at the 5%
level. Examining assoiations for 30 specific cancers for three
different categories of radionuclide monitoring, increases the prob-
lems inherent with multiple significance testing. When interpreting,
the results. we therefore emphasize associations for cancers of
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Table 5 Rate ratios for death from all malignant neoplasms and selected cancers in radiation workers in three UK workforces (AEA. AWE. Sellafield)
monitored for radionuckides according to age at first monitoring and calendar year of first monitoring
Rate ratios (number of deaths)
All malignant neopl Bronchus and lung Prostate
Radionuclide monitored for Radionuclide monitored for Radionuclide monitored for
Tritium Plutonium Other Tritium Plutonium Other Tritium Plutonium Othw
Age at first monitoring (years)
< 35 1.05 (24) 1.13 (134) 1.09 (61) 0.75 (3) 1.19 (30) 1.22 (13) 3.06 (2) 0.94 (4) 3.54- (5)
35- 0.93 (37) 1.03 (158) 0.95 (79) 1.29 (13) 1.13 (56) 1.30 (31) - (0) 0.53 (5) 1.18 (4)
45- 1.10(62) 1.05(191) 1.22-(161) 1.27(24) 1.30 (88) 1.37(66) 1.61 (6) 0.93(12) 1.65(13)
55+ 0.98(42) 0.82(98) 1.04(117) 1.12(17) 1.01 (43) 1.26(54) 1.58(6) 1.18(11) 1.53(15)
X2 for heterogeneity (d.f. = 3) 0.74 5.56 3.51 0.91 1.88 0.27 7.30 2.06 2.32
X2 for trend (d.f. = 1) 0.001 3.76 0.07 0.04 0.16 0.0002 0.24 0.86 0.44
Calendar year of first monitoring
Pre 1960 0.98 (41) 1.10 (318) 1.20^ (155) 1.30 (16) 1.14 (111) 1.16 (50) 1.50 (4) 1.15 (20) 2.30' (15)
1960- 1.01 (53) 0.99(139) 1.06(102) 1.24(20) 1.30(58) 1.40 (45) 0.59(2) 0.67(6) 1.50(8)
1965- 1.11 (36) 0.94 (48) 1.12 (84) 1.09 (11) 1.25 (20) 1.67 (41) 2.49 (5) 0.23 (1) 1.74 (9)
Post 1969 1.02(35) 0.79 (76) 0.88(77) 1.01 (10) 1.02 (28) 1.09(28) 1.32 (3) 1.02 (5) 0.81 (5)
x2 for heterogeneity (d.f. = 3) 0.31 6.05 4.64 0.48 1.26 3.93 3.29 4.27 4.09
X2 for trend (d.f. = 1) 0.11 5.91' 3.47 0.46 0.06 0.09 0.13 0.83 3.08
aRelative to radiation workers not monitored for any radionuclide. adjusted for age, sex, calendar period. social class and establishment. Statistcal significance.
'2P < 0.05: -2P < 0.01 '''2P < 0.001.
greatest interest on the basis of previous analvses. particularly
cancers ofthe lung and prostate.
RESULTS
Descriptive statistics
Of the 40 761 workers who had been monitored for exposure to
extemal radiation. 57% had never been monitored for exposure to
one or more radionuclides. 10% had been monitored for tritium.
31% had been monitored for plutonium and 25% were monitored
for other radionuclides (uranium. polonium. actinium or other
unspecified radionuclides) (Table 1). Ofthe 17 605 workers moni-
tored for any radionuclide. 9949 were monitored for tritium alone.
plutonium alone or other radionuclides alone.
Mortality relative to national rates (SMRs)
A total of 4149 deaths were observed in radiation workers not
monitored for exposure to any radionuclide and this group experi-
enced mortalitv rates that were 20% lower than those expected on
the basis of national rates (SMR = 80. 95% CI 75-85). Similarly
low relative mortality was seen for deaths from all cancers
combined and for all causes of death other than cancer (Table 2).
SMRs for these broad cause of death categories were also signifi-
cantly (2P < 0.05) below 100 for workers monitored for tritium.
plutonium and other radionuclides. There were no specific cancers
for which SMRs were significantly high in workers monitored for
tritium. but a significantly raised SMR was seen for cancer of the
pleura among workers monitored for plutonium (SMR = 357. 95%
CI 163-4307: 2P = 0.002) and for cancer of the prostate among
workers monitored for other radionuclides (SMR = 153. 95% CI
108-211: 2P = 0.02). Significantly low SMRs were seen for cancer
of the lung, among, workers monitored for tritium. for cancer of the
lung and buccal cavitv and pharynx among workers monitored for
plutonium. and for cancer of the bladder and pancreas amonc
workers monitored for other radionuclides (Table 2).
Mortality relative to that of radiation workers not
monitored for radionuclides (RRs)
Among workers monitored for tritium exposure. death rates for
causes other than cancer were sicnificantlI below those ofAworkers
not monitored for any radionuclide (RR = 0.88. 95%7 CI 0.78-
0.98). Apart from this, there was little evidence that the overall
death rates from cancer in workers monitored for radionuclide
exposure differed from those of workers not monitored for any
radionuclide (Table 2). In tritium-monitored workers. three deaths
observed from testicular cancer constituted a statistically signifi-
cant excess (RR = 8.37. 95% CI 1.48-43.14: 2P = 0.02). Among
workers monitored for plutonium. there were no specific cancers
with rates above those of workers not monitored for any radio-
nuclide. but a significantly lower rate was observed for deaths
from cancers of the buccal cavity and pharynx and thyroid (Table
2). Workers monitored for other radionuclides experienced signifi-
cantly higher rates than non-monitored workers for cancers of the
lung (RR = 1.31. 95% CI 1.06-1.61: 2P = 0.01). uterus (RR =
7.28. 95% CI 1.10-47.81: 2P = 0.04) and prostate (RR = 1.65.
95% CIn 1.03-2.65: 2P = 0.03). Significantly lower rates were
observed for cancers of the buccal cavity and pharynx (RR = 0. 13.
95% CI 0.01-0.69). oesophagus (RR =0.46.95%c CI 0.20-0.97) and
thyroid (RR = 0.00. 95%c CI 0.00-0.88) in this group ofworkers.
Ofthe 164 lung cancer deaths reported in workers monitored for
other radionuclides. 83 occurred in workers aged under 65 years
(RR = 1.36. 95% CI 1.00-1.83. 2P = 0.05). 60 in workers agyed
between 65 and 74 (RR = 1.18. 95%c CI 0.84-1.64. 2P = 0.3) and
21 in workers aged 75 or more (RR = 1.56. 95%cCI 0.86-2.76. 2P
= 0.1). For prostatic cancer. the raised death rate was more evident
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Table 6 Rate ratiosa for death from all malignant neoplasms and selected cancers in radiation workers in three UK workforces (AEA. AWE.
Sellafield) monitored for radionuclide exposure according to level of cumulative whole body dose (numbers of deaths in parentheses)
Cumulbtive whole-bdy dose (mSv)
Cause of death Radionuclide
(ICD 8th revision code) monitored for <10 10 + Total
All malignant neoplasms (140-209) Trtium 1.07 (32) 1.01 (133) 1.02 (165)
Plutonium 0.91 (100) 1.04 (481) 1.01 (581)
Other 1.07 (114) 1.09 (304) 1.09 (418)
Bronchus and lung (162) Trrtium 1.86' (15) 1.05 (42) 1.18 (57)
Plutonium 1.11 (37) 1.20 (180) 1 18 (217)
Other 1.44' (46) 1.29' (118) 1.31' (164)
Prostate (185) Trtium 0.89 (2) 1.39 (12) 1.33 (14)
- Plutonium 1.03 (7) 0.87 (25) 0.90 (32)
Other 1.61 (10) 1.57 (27) 1.65' (37)
aRelative to radiation workers not monitored for any radionuclide. adjusted for age. sex. calendar period. social class and establishment.
Statistical significance: '2P < 0.05.
in workers aged 75 or more (RR = 2.89. 95%e CI 1.19-7.08. 2P =
0.02: based on 12 deaths) than al ages belowv 65 (RR = 1.65. 95%
CI 0.69-3.94. 2P = 0.3: 12 deaths) or at ages 65-74 (RR = 1.12.
95%7 CI 0.52-2.33. 2P = 0.8: 13 deaths.)
Characteristics of radionuclide monitoring
For cancers of the lung and prostate. and all cancers combined.
further analyses were performed to examine the effects of time
since first monitorin,. the number ofyears in which workers were
monitored (AEA and AWE only). age at first monitorinn and
calendar year of first monitoring (Tables 3-5). For tritium-moni-
tored workers. and workers monitored for radionuclides other than
tritium or plutonium. there wvas little evidence that RRs varied
according to the time period since first monitoring (Table 3).
Among plutonium-monitored workers. however. some sariation
wxas seen in the RRs for all cancers combined: relatiVe to workers
not monitored for any radionuclide. death rates were lowest durint
the 10 years folloswing first monitoring (RR = 0.79. 95%c CI
0.64-0.97). intermediate during the period 10-19 sears (RR =
0.95. 95%c CI 0.80-1.12) and highest during the period 20 years or
more after first monitoring (RR = 1.20. 95% CI 1.03-1.38). The
variation in these three RRs was statisticall significant (X for
heterogeneity = 12.91. d.f. = 2: 2P = 0.002). this being largelv due
to linear trend (X' for trend = 12.86. 2P = 0.0003).
Analyses of mortality in relation to number of years since first
monitoring for plutonium were also carried out for indis idual
cancers. The trend observed for all cancers combined did not
appear to be explained by any single cancer: the strongest
esvidence for an association was observed for all lymphatic and
haematopoietic cancers (X for linear trend = 6.74. 2P = 0.009). the
RRs being 0.50 for less than 10 years. 0.84 for 10-19 years and
1.60 for 20 or more years. Within this group of cancers. trends
were significant separately for multiple myeloma and leukaemia
but the numbers of deaths in each category of time since first
monitoring were small: 0. 0 and 6 for multiple myeloma and 0. 4
and 7 for leukaemia. In addition. a significant trend of increasingr
risk with time since first monitoring, was observed for cancer of
the brain and ovary. but again the numbers ofdeaths in each cate-
gory of time since first monitoringc were relatively small: 2. 4 and
7 for brain and 0. 0 and 2 for ovars. Althouah no other cancer
demonstrated a statistically significant association. for seseral
(e.g. lung) there was a non-significant increase in risk with time
smce first monitoring for plutonium.
For radiation workers who had only been employed by the AEA
or AWE. data were available on duration of monitorin2. Amona
tritium-monitored workers. RRs for all cancers combined and for
lung, cancer varied little according to the number ofyears in which
workers had been monitored (Table 4). For prostatic cancer.
however. significant variation was seen uwith number of vears
monitored (X' for heterogeneity = 7.16. d.f.= 2: 2P = 0.03). rates
being, highest in workers monitored in 2-4 vears (RR = 3.19. 95%
CI 1.15-7.54). For workers monitored for plutonium. RRs for all
cancers combined increased with the number of years in which
workers were monitored (X' for trend = 4.38. 2P = 0.04). For lung,
cancer. the highest RR wvas in workers who were monitored for
plutonium for 5 or more years (RR = 1.45. 95%r CI 1.06-1.961
although neither the heterogeneity nor trend in RRs was statisti-
cally significant. There was no statistically significant variation in
RRs for all cancers combined. or for cancers of the lung or
prostate. with number of years in which workers were monitored
for other radionuclides.
There was little suggestion that RRs s-anred according to age at
first monitoring or calendar vear of first monitoring in workers
monitored for tritium or radionuclides other than tritium or pluto-
nium (Table 5). Among workers monitored for plutonium expo-
sure there was a tendency for RRs for all cancers combined to be
higher in earlier calendar periods (X' for trend = 5.91. 2P = 0.02)
but none of the calendar period-specific RRs was significantly
different from unity.
Radionuclide monitoring status and cumulative
extemal radiation dose
In order to investigate the potentially modifAing effects ofexternal
radiation dose on the above findings. RRs were estimated sepa-
rately for workers receiving less than 10 mSv ofexternal dose and
those receiving 10 mSs or more (Table 6). These analyses revealed
a statistically significant excess of lung cancer among tritium-
monitored workers who had receis ed less than 10 mSs ofexternal
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Table 7 Mortality among raatbo workers in three UK workoces (AEA, AWE, Selae) in relabt to cumulative wholxbody dose for all cancers combined
and selected cancers according to raconucle monitorig status. Acpusted for age, sex, calendarperiod, social and establishent
-o fortrend
CumnxdaMlv whole-body dose (mfSv)- Lag period
Causeof death Radin <10 10- 20- 50- 100- 200- 400+ Totl 0yewrs 10 yeaws
(ICD 8th reiin mntrd deahs
code) for
Al malinant Any 0.95 0.89 1.07 1.03 1.04 1.14 0.80 798 - 0.89 - 0.49
neopasrns (140-209) (156/163.48) (78J87.82) (162/151.76) (122/118.25) (114/110.09) (108/94.44) (58(72.16)
None 0.99 0.99 1.00 1.18 0.83 1.05 0.98 1097 + 0.11 + 0.22
(575/582.73) (160/161.26) (191/190.53) (93/78.81) (34/40.88) (29/27.53) (15/15.26)
Bronchus and lung Any 1.04 0.97 1.00 1.16 0.95 1.15 0.59 295 -2.02 - 1.50
(162) (62/59.47) (30/31.00) (53/53.20) (50/43.16) (41/43.37) (43/37.54) (16/27.25)
None 1.00 0.78 1.02 1.32 1.34 0.76 0.97 348 + 0.25 + 0.29
(181/180.11) (42/53.86) (6362.06) (3324.99) (17/12.64) (7/9.20) (5/5.14)
Pleura (163) Any 0.70 0.00 1.16 1.52 2.21 0.81 0.00 9 -0.79 - 0.46
(1/1.42) (0/0.97) (2/1.73) (2/1.32) (3/1.36) (1/1.24) (0/0.97)
None 1.01 1.39 1.31 0.00 0.00 2.45 0.00 9 - 0.35 - 0.27
(4/3.97) (2/1.43) (2/1.53) (C0/.80) (0/0.59) (1/0.41) ((0/026)
Melanoma and other Any 0.52 0.70 1.16 0.78 2.62 0.00 3.64 8 + 1.47 + 1.89
skin (172-173) (1/1.92) (1/1.44) (2/1.73) (1/1.28) (2/0.76) (00.60) (1/0.27)
None 0.62 1.09 0.00 3.68 2.56 4.10 0.00 8 + 1.37 + 2.17'
(3/4.81) (1/0.92) (0/0.99) (2/0.54) (1/0.39) (1/0.24) (w0.11)
Uterus Any 1.77 0.00 0.00 3.75 0.00 0.00 0.00 3 -0.08 - 0.94
(180-182) (2/1.13) (0/0.14) (0/1.39) (1/0.27) (0/0.08) ((/0.00) (0/0.00)
None 1.11 0.00 0.72 2.98 0.00 0.00 0.00 10 + 0.54 + 1.02
(8(7.21) (0/1.08) (1/1.38) (1/0.34) (0/0.00) ((0/.00) ((01.00)
Prostate (185) Any 0.90 0.56 1.09 0.80 1.64 1.57 0.26 50 - 0.51 - 1.01
(10/11.10) (3/5.31) (12/10.99) (6'7.49) (10;.08) (8/5.11) (1/3.92)
None 0.98 0.98 0.89 1.40 0.79 1.54 0.78 62 + 0.21 + 0.21
(30/30.63) (8/8.19) (11/12.42) (7/5.01) (2/2.52) (3/1.95) (1/1.29)
11-defined and Any 1.09 0.81 1.10 0.62 0.57 1.75 1.12 57 + 1.01 + 1.12
secondary (195-199) (13/11.96) (6J7.42) (13/11.80) (5/8.04) (417.04) (11/6.28) (5/4.46)
None 0.91 1.18 1.26 0.92 0.55 0.86 1.73 60 + 0.33 + 0.48
(32/35.26) (97.63) (13/1029) (3/3.25) (1/1.83) (1/1.16) (1/0.58)
Multiple Any 1.10 0.00 0.00 2.87 0.99 0.00 1.65 9 + 0.56 + 1.09
nmyeoma (203) (2/1.82) (0/0.87) (0/1.57) (4/1.39) (1/1.01) (0/1.14) (2/1.21)
None 0.97 0.82 1.38 0.00 3.24 0.00 0.00 8 -0.09 - 0.66
(4/4.12) (1/1.23) (2/1.44) (0/0.67) (1/0.31) (0/0.17) (0/0.06)
Leukaemia Any 0.53 0.49 1.09 0.89 0.44 2.00 1.66 15 + 1.67' + 1.79'
exciuding CLL (1/1.89) (1/2.05) (3/2.76) (2/2.24) (1/227 (4/2.00) (3/1.80)
None 1.09 0.59 0.64 1.65 1.67 0.00 5.64 34 + 1.43 + 1.62
(20/18.38) (3/5.05) (4/624) (4/2.43) (2/1.20) (010.53) (1/0.18)
Results are expressed as ratio of observed to expected deaths [observed and expected numbers of deaths in parantheses; expected deaths are based on all
subjec wih a radion record (any or none, as apropriae)J. *Jumbrs shown in body of table are based on a lag period of 0 years. bBased on mean
exposures in each category weighted accorg to the distrbubon ot person years at risk in each category: means were 3.38, 14.41, 32.57, 70.80, 141.28,
279.26 and 585.68 mSv for lag = 0 years; 2.83, 14.42, 32.57, 70.80, 141.24, 278.92, 583.18 mSvfor lag = 2 years and 1.36, 14.44, 32.54, 70.75, 140.73,
277.10 and 565.45 mSv for lag = 10 years. 'ag period of 2 yearsfor eukaemia. Statstcal sig n, 1 P< 0.05.
dose (RR = 1.86, 95% CI 1.01-3.17), but there remained little
suggestion of an excess among tritium-monitored workers with
doses ofl0 mSv or more (RR = 1.05,95%CI0.74-1.45).RRsfor
workers monitored for plutonium exposure appeared relatively
unaffectedby stratification forlevel ofextemal radiationdose. The
previously noted excess death rate for lung cancer in workers
monitored for other radionuclides was present and separately
statistically significant for workers with less than 10 mSv and for
those with 10 mSv or more of external dose (Table 6). Although
the overall excess death rate forprostatic cancer in workers moni-
tored for other radionuclides was evident in both subgroups of
workers, neitherofthe individual RRs was statistically significant.
In ourearlierreport(Carpenter et al, 1994),we described cancer
mortality in relation to cumulative external radiation dose in this
cohort of 40 761 radiation workers during the same period of
follow-up and found statistically significant positive associations
for leukaemia (excluding chronic lymphatic leukaemia, CLL),
melanoma and other skin cancers and ill-defined and secondary
cancers. Table 7 shows the results ofperforming similar analyses
with additional stratification for radionuclide monitoring status
defined asmonitoring foranyradionuclide vsmonitoring for none.
It can be seen that death rates from leukaemia excluding CLL and
melanoma and other skin cancers increased with external radiation
dose in both groups of worker (Table 7). The association for
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ill-defined and secondary cancers. however, was less evident when
stratified by radionuclide-monitoring status. For other specific
cancers examined (lung, pleura, uterus, prostate and multiple
myeloma) there continued to be little evidence ofa trend foreither
subgroup ofworker.
DISCUSSION
The effects ofoccupational exposure from intemal contamination
by radionuclides have been relatively little studied. This contrasts
with the large body of results from studies of cancer risks in
workers exposed to extemal radiation. Unlike extemal radiation.
intemal doses from radionucides are likely to be non-uniform
across the body and are often extremely difficult to infer. Although
monitoring for radionuclide exposure has been carried out
routinely in nuclear industry workforces, detailed estimation of
doses from intemal sources have generally not been made. The
main exception in the UK is the Sellafield workforce, for which
annual plutonium doses have been assembled for the purpose of a
special study and this is to be the subject ofa separate report. The
analyses described here rely solely on information as to whetheror
not workers were monitored for exposure to internal contamina-
tion by radionuclides. Being monitored for aradionuclide does not
necessarily mean that the individual concerned was actually
exposed to it. These issues need to be bome in mind when inter-
preting the results (Atkinson et al, 1994).
Of the few studies that have examined the carcinogenic effects
of exposure to radionuclides in nuclear industry workers occupa-
tionally exposed to tritium, 5'Cr, -9Fe, 6&Co or 65Zn were found to
be at an increased risk ofprostatic cancer, but the separate effects
of these individual radionucides could not be disentangled
(Rooney et al, 1993). Many of those workers are included in the
present study and so it is not surprising that an excess ofprostatic
cancer was found here in workers monitored for radionuclides
other than tritium or plutonium (Table 2) and that AEA and AWE
employees monitored for tritium in 2 or more years had risks two
to three times those of radiation workers not monitored for any
radionucide (Table 4). Three deaths from testicular cancer in
tritium-monitored male workers constituted a significant excess
relative to rates in workers not monitored for any radionuclide, as
did three deaths from cancerofthe uterus in female workers moni-
tored for radionucides other than plutonium and tritium (Table 2).
These findings are based on a small number of deaths and may
have arisen by chance.
whe strength of prior evidence for an excess of lung cancer in
nuclear industry workers monitored forexposure to radionuclides is
not strong for workers in the UK or USA (Wilkinson et al. 1987:
Beral et al, 1988; Checkoway et al, 1988; Gilbert et al, 1989; Wmg
et al. 1991; Fraser et al, 1993). However, workers exposed to pluto-
nium in the radiochemical plant at Mayak, Russia, have a large
excess risk of lung cancer (Koshurnikova et al. 1997). Among
workers monitored forplutonium exposure inthepresent study. lung
cancermortaLity was increased in those whohadbeen monitored for
such an exposure for 5 or more years (Table 4). Plutonium-moni-
tored workers also experienced a trend of increasing death rates
from all cancers combined in relation to time since first monitoring
and duration ofmonitoring. The trend in relation to time since first
monitoring was in part due to a non-significant increase in lung
cancer and in part due to a significant increase in other specific
cancers, most notably those of the lymphatic and haematopoietic
system. Separate analyses currently underway on the Sellafield
workforce could 'provide independent evidence regarding these
associations, as well as the opportumty to investigate patterns of
cancer risk in relation to the estimated level ofplutonium exposure.
Death rates from lung cancer in workers monitored for radionu-
clides other than tritium and plutonium were also 31% higher than
those ofworkers not monitored for any radionucide (Table 2).
An excess of pleural cancer has been noted previously among
radiation workers employed at Sellafield (Douglas et al, 1994). As
in the previously reported datarelating to the Sellafield woriforce.
the present study provides no suggestion for a relationship
between pleural cancer and external radiation dose (Table 7). All
pleural cancer deaths observed were mesotheliomas but, in the
absence ofdata relating to exposure to asbestos, the increased risk
ofcancerofthe pleura in plutonium-monitored workers is difficult
to interpret.
As noted above, the lack of dosimetric data for internal expo-
sures has implications for the interpretation of findings reported
here. A furter consideration is the possible biasing effect that
these exposures may have had on previous analyses ofmortality in
relation to external radiation (Carpenter et al. 1994). In order to
examine this issue, analyses of the relation between cancer
mortality and external dose were repeated separately for radiation
workers monitored for any radionucide and those monitored for
none (Table 7). As before, these analyses continued to provide no
suggestion of an association with extemal dose for all cancers
combined whereas, for leukaemia. there was very little evidence
that the strength of association differed between these two groups
of worker. These findings are broadly similar to those obtained
from data for the National Registry for Radiation Workers (which
included the majority of workers in the present study), although
there was less evidence in the current analyses that the increase in
leukaemia mortality with extemal dose was stronger in workers
not monitored for internal contamination (Little et al, 1993).
CONCLUSIONS
These analyses of cancer mortality in relation to monitoring for
radionuclide exposure reported in a large cohort of nuclear
industry workers suggest that certain patterns of monitoring for
some radionucides may be associated with higher death rates
from cancers of the lung. pleura. prostate and all cancers
combined. Some of these findings may be due to chance.
Moreover, because ofthe paucity ofrelated data and lack ofinfor-
mation about otherpossible exposures. such as whetherplutonium
workers are more likely to be exposed to asbestos, firm conclu-
sions cannot be drawn at this stage. Further investigations of the
relationship between radionuclide exposure and cancer in nuclear
industry workers are needed.
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